Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

Fig. 3

Association between HER2 s/n and immunophenotypical factors. The 64 breast carcinomas presenting 4.0–5.9 HER2 s/n included in our study have a significantly higher percentage of estrogen (p = 0.016) and/or progesterone (p = 0.001) positivity, and a lower percentage of Ki67 proliferation index (p = 0.027) than highly amplified tumors (≥6.0 HER2 s/n)

Back to article page